Skip to content

XBiotech Inc Sustainability Reports

XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating various inflammatory and infectious diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 5299002WACAY28TQAS52

FIGI: BBG0081S8D48

4 reports from 2017 to 2024